Sofosbuvir Completed Phase 3 Trials for Human Immunodeficiency Virus (HIV) / Hepatitis C Virus (HCV) Infection Treatment

CompletedTreatment3 IdentifierTitleDrugs
NCT02073656Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection
NCT01838590Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection